The T-Cell Response to COVID-19 Infections and Immunity
Story Highlights Rapid decline of neutralizing antibodies following COVID-19 infection in some people have led to concerns that immunity to the SARS-CoV-2 virus Is temporary. However, several recent studies have shown a presence of virus-specific T-cells that remain, including among patients with mild or asymptomatic infections. Long-lasting immunity after recovery from COVID-19 infection may be […]
ACIP Updates Influenza Vaccine Guidelines for Seniors
The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) has issued new updates for influenza vaccines for 2020–2021 “flu season,” primarily for Fluzone and Fluad vaccines. In November 2019, U.S. Food and Drug Administration (FDA) licensed inactivated injectable Fluzone High-Dose Quadrivalent (HD-IIV4) for use in persons aged […]
